Using DNA as a key, our device has the potential to detect anything ranging from bacterial or viral infection to cancer and tumor malignancy. Our diagnostic tool is only limited by what can and cannot be detected through DNA analysis, which stops short of conditions such as poisoning or physical trauma.
Currently, 3DIMAGENE is focusing on developing a blood test that detects bacterial and viral infections, coupled with indication of antibiotic or antiviral resistance. After the finalization of the core device, we will move on to create other diagnostic test cartridges.
Our current process (in the sequence of the video) utilizes electrowetting, digital PCR (Polymerase Chain Reaction), and IC3D technology.
The electrowetter will allow for the device to both break open the cells to release the DNA and mix the blood sample with the chemical reagents contained in the test cartridge.
Digital PCR will iincrease the speed of the device and allow for the calculation of the concentration of the target specimen. This means that the product will be able to identify which bacteria is present in the sample and provide the concentration of that bacteria.
The IC3D technology will significantly reduce the time required to analyze the post PCR sample. It is also the key component that will allow 3DIMAGENE to calculate the cocnentration of bacteria in the sample.